论文部分内容阅读
我院自1991年初开始用超滤法研制心脑脉舒口服液,临床用于治疗冠心病心绞痛等,经84例患者治疗表明,对心绞痛疗效的总有效率为86.9％,静息心电图改善总有效率为77％。现就其制备、质量标准及临床观察报告如下:
In our hospital, since the beginning of 1991, Xinmaoshu oral liquid has been developed by ultrafiltration, and it has been clinically used for the treatment of angina pectoris of coronary heart disease. After treatment in 84 patients, the total effective rate for the treatment of angina is 86.9%, and the resting electrocardiogram improves the total The effective rate is 77%. Its preparation, quality standards and clinical observation report are as follows: